| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/23/1995 | DE3991484C2 Pharmaceutical composition containing a specific inhibitor of the enzymatic conversion of protoporphyrinogen to protoporphyrin IX by protoporphyrinogen oxidase |
| 02/23/1995 | CA2169833A1 Chitinase, dna coding therefor and plants containing same |
| 02/23/1995 | CA2169280A1 Amidine derivatives with nitric oxide synthetase activities |
| 02/23/1995 | CA2146667A1 Lipopolysaccharide-binding and neutralizing peptides |
| 02/22/1995 | EP0639642A1 Chitinase, DNA coding therefore and plants containing same |
| 02/22/1995 | EP0639640A1 Poultry vaccine containing infections bronchitis virus serotype 4/91 |
| 02/22/1995 | EP0639195A1 2-acyloxycephem derivatives as elastase inhibitors |
| 02/22/1995 | EP0639193A1 Esters of antibacterial condensed carbapeneme derivatives |
| 02/22/1995 | EP0639184A1 New quinazolines as inhibitors of hiv reverse transcriptase |
| 02/22/1995 | EP0639081A1 Vaccine compositions for mucosal delivery |
| 02/22/1995 | EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 02/22/1995 | EP0639075A1 Specific inhibition of dihydrofolate reductase and compounds therefor |
| 02/21/1995 | USRE34865 Antibiotics |
| 02/21/1995 | US5391746 Inhibitors of lentiviruses; deoxynojirimycin derivatives |
| 02/21/1995 | US5391367 Antifungal nail solution |
| 02/19/1995 | CA2117503A1 Azoxycyanobenzodioxane derivatives |
| 02/16/1995 | WO1995004817A1 Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of ctl |
| 02/16/1995 | WO1995004752A1 Therapeutic peptide derivatives |
| 02/16/1995 | WO1995004545A1 Inactivated respiratory syncytial viral vaccines |
| 02/16/1995 | WO1994029472A3 Mengovirus as a vector for expression of foreign polypeptides |
| 02/16/1995 | WO1994023028A3 Modified oligonucleotides having improved anti-influenza activity |
| 02/16/1995 | CA2168950A1 Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of ctl |
| 02/16/1995 | CA2168566A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 02/15/1995 | EP0638587A1 Salmycins, a process for their preparation and their use as a pharmaceutical |
| 02/15/1995 | EP0638586A2 Nucleoside derivatives and methods for producing them |
| 02/15/1995 | EP0638583A1 Aminosugar active substances, a process for their preparation and use as pharmaceuticals |
| 02/15/1995 | EP0638574A1 Oxime derivatives of cephalosporanic structure and compounds for their preparation |
| 02/15/1995 | EP0638316A1 Recombinant adenovirus vaccines |
| 02/15/1995 | EP0638126A1 Inhibitory factor |
| 02/15/1995 | EP0638104A1 Undecylenic acid derivatives with hydrophilic molecules and utilizations in cosmetics or in pharmacy |
| 02/15/1995 | EP0638092A1 Synthetic peptide vaccines for dental caries |
| 02/15/1995 | EP0638080A1 7-DISUBSTITUTED-METHYL-4-OXO-3H -,5H --PYRROLO 3,2-d -]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME |
| 02/15/1995 | EP0637963A1 Cd28 pathway immunoregulation |
| 02/15/1995 | EP0637960A1 SUBSTITUTED INDOLIZINO 1,2-b]QUINOLINONES |
| 02/15/1995 | EP0637959A1 Soluble analogs of probucol |
| 02/15/1995 | EP0587780B1 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 02/15/1995 | EP0573538B1 Peptides for treatment |
| 02/15/1995 | EP0425507B1 Compositions and methods for treating skin conditions and promoting wound healing |
| 02/15/1995 | CN1098715A 1H-indole-3-acetamide spla2 inhibitors |
| 02/15/1995 | CN1098714A 1H-indole-3-acetic acid hydrazide spla2 inhibitors |
| 02/14/1995 | US5389676 A water in oil or oil in water antibacterial emulsion comprising betaines and amine oxides, hydrophobic materials, water soluble nonionic, cationic surfactants; stability, bactericides, antiseptics; soap, shampoo, wound healing agent |
| 02/14/1995 | US5389625 Sweet taste; oral administering |
| 02/14/1995 | US5389612 Phosphonic peptide inhibitors of bacterial collagenases |
| 02/14/1995 | US5389609 Antifungal preparations, and process for making such preparations |
| 02/14/1995 | US5389540 Employing a DNA coding sequence having a (G+C) content that has been increased in the region from nucleotide 410 to the 3' end of the coding sequence relative to wild-type DNA sequence |
| 02/14/1995 | US5389528 Isolated DNA sequence encoding polypeptide identifiable as component of hepatitis delta antigen |
| 02/14/1995 | US5389373 Preparation of oil-in-water emulsions of drugs |
| 02/14/1995 | US5389369 Halo peroxidase containing compositions for killing yeast and sporular microorganisms |
| 02/14/1995 | CA1334470C Antithrombogenic and antibiotic compositions and methods of preparation thereof |
| 02/14/1995 | CA1334424C Thiochroman esters of phenols and terephthallates having retinoid-like activity |
| 02/14/1995 | CA1334414C Discorhabdin compositions and their methods of use |
| 02/14/1995 | CA1334413C Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters |
| 02/14/1995 | CA1334407C Method for the preparation of novel alcoyloxime derivatives of 7-amino-thiazolyl-acetamido-cephalosporanic acid |
| 02/14/1995 | CA1334388C Vaccine suitable for prophylaxis and control, respectively, of the pig disease caused by haemophilus pleuropneumoniae as well as a method for obtaining extracellular proteinaceuosmaterial of haemophilus pleuropneumoniae suitable for use in such vaccines |
| 02/14/1995 | CA1334387C Feline leukemia virus vaccine |
| 02/12/1995 | CA2130202A1 Recombinant adenovirus vaccines |
| 02/10/1995 | CA2128557A1 Oxime derivatives of cephalosporanic structure and compounds for their preparation |
| 02/09/1995 | WO1995004135A1 Fungicidal methods and compositions for killing yeast and sporular microorganisms |
| 02/09/1995 | WO1995004133A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 02/09/1995 | WO1995004081A1 MONOCLONAL IgA ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS |
| 02/09/1995 | WO1995004080A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | WO1995004065A1 Processes and intermediates for phosphorous-containing covalent linkages |
| 02/09/1995 | WO1995004060A1 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity |
| 02/09/1995 | WO1995004059A1 Novel benzothiophene analogs as antiviral agents |
| 02/09/1995 | WO1995004045A1 Compounds as pde iv and tnf inhibitors |
| 02/09/1995 | WO1995004034A1 (thio)carbimidinic acid derivatives and medicaments containing the same |
| 02/09/1995 | WO1995003825A1 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| 02/09/1995 | WO1995003824A1 Treatment of h. pylori associated gastroduodenal disease |
| 02/09/1995 | WO1995003812A1 T-lymphocyte-containing pharmaceutical composition for treating infections |
| 02/09/1995 | WO1995003799A1 Use of benzydamine in the treatment of pathological conditions caused by tnf |
| 02/09/1995 | WO1995003792A1 Use of thiol compounds in the therapy of viral diseases |
| 02/09/1995 | WO1995003777A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 02/09/1995 | WO1995003775A1 Antifungal nail solution |
| 02/09/1995 | CA2168463A1 Novel benzothiophene analogs as antiviral agents |
| 02/09/1995 | CA2168263A1 Pharmaceutical compositions |
| 02/09/1995 | CA2168231A1 (thio)carbimidinic acid derivatives and pharmaceutical agents containing them |
| 02/09/1995 | CA2168230A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | CA2167938A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 02/09/1995 | CA2167835A1 Monoclonal iga antibody against respiratory syncytial virus |
| 02/09/1995 | CA2167730A1 Synthetic multiple tandem repeat mucin and mucin-like peptides and uses thereof |
| 02/09/1995 | CA2167671A1 Processes and intermediates for phosphorous-containing covalent linkages |
| 02/08/1995 | EP0637591A2 A novel expression vector for phytolacca antiviral protein |
| 02/08/1995 | EP0637333A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 02/08/1995 | EP0637316A1 Antisense oligonucleotide inhibition of papillomavirus |
| 02/08/1995 | EP0637300A1 Antiproliferative quinazolines |
| 02/08/1995 | EP0637250A1 Inactivated mycoplasma hyopneumoniae and uses therefor |
| 02/08/1995 | EP0637247A1 Treatment of herpesvirus infection |
| 02/08/1995 | EP0637203A1 Regulation of the immune system |
| 02/08/1995 | CN1098404A Inhibitors of HIV protease useful for the treatment of aids |
| 02/08/1995 | CN1098295A Zhishiqingjie injection |
| 02/08/1995 | CN1098285A Perfume for curing tinea manuum and tinea pedis |
| 02/07/1995 | US5387748 Antimicrobial dithiocarbamoyl quinolones |
| 02/07/1995 | US5387670 Antibiotic, deoxymulundocandin, a process for its production and its use as medicament |
| 02/07/1995 | US5387414 Comprising peptide immunogen with novel epitopes |
| 02/07/1995 | CA2083945C An antiviral composition |
| 02/07/1995 | CA2030911C Pharmaceutical preparations |
| 02/07/1995 | CA1334287C Biologically active peptides tan-866 |
| 02/02/1995 | WO1995003416A1 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid |
| 02/02/1995 | WO1995003415A2 Epstein-barr virus dna sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests |
| 02/02/1995 | WO1995003414A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |